News About: R&D
Questions arise on antiulcerant effect of COX-2 inhibitor
Cyclooxygenase-2 (COX-2) inhibitor, a novel nonsteroidal anti-inflammatory drug (NSAID), has been used to treat arthritis by highlighting its advantage in advertisement over other NSAIDs in that COX-2 inhibitor causes...
R&D investment effects in pharmaceutical industry near visible.
The R&D investment effects of the pharmaceutical industry came up to its visible borderline.
Dr. Kim Jong-kwon, the researcher responsible for the policy and strategy planning team of the Korea Health Industry Prom...
KISTEP earmarks 2003 BT budget at 496.2 billion won
Korea's R&D budge is expected to further grow in parallel with the government's intensive policies to foster new promising technologies in the related fields, a government agency said.
The Korea Institute of Scienc...
Clinical trials underway for 41 new drugs
The Korea Food and Drug Administration says the current clinical trials are underway for 41 new drugs in 2002, showing a slight decreased compared with 45 new drugs a year earlier. Of the 41 new drugs, new drugs accou...
KFDA approves zoledronic acid
Novartis Korea announced that it has recently received marketing authorization from the Korea Food and Drug Administration for Zometa (zoledronic acid), a highly potent intravenous bisphosphonate, for the treatment of...
58% research institutes planned R&D investment up next year.
According to a recent survey conducted by the Korea Industrial Technology Promotion Association against 621 domestic firms, more than a half (57.7%) of them will increase their R&D investment next year while 38.2% kee...
7 out of 10 men improved erections
70% of men with erectile dysfunction improved erections after taking Levitra (vardenafil), according to the reports presented by the 5th Congress of the European Society for Sexual and Impotence Research (ESSIR) in Ha...
Drug industry to visualize R&D investment for Chinese market.
20 leading pharmaceutical companies have visualized their business entry into China including R&D plans in association with NHTP, a Chinese national class of health and science industrial park.
The Korea New Drug D...
Korea should promote incessant development of herbal medicines towards potential OTC formulations
In the midst where many countries are greatly endeavoring to develop herbal medicines for the expansion of OTC drugs, Korea has witnessed little progress in the related herbal medicine sector due to conflict of intere...
Patent registration applications for antihypertensive agents up
The Korean Intellectual Property Office (KIPO) says that the applications for the registration of antihypertensive agents have been gradually increased thanks to more intensive R&D efforts of pharmaceutical firms in t...
